Skip to main content

Table 2 Characteristics of patients

From: Review by urological pathologists improves the accuracy of Gleason grading by general pathologists

 

Overall (n = 755)

Apr./06-Sep./06 (n = 197)

Oct./06-Mar./07 (n = 225)

Apr./07-Sep./07 (n = 185)

Oct./07-Mar./08 (n = 148)

p Value

Age (median: yrs)

71 (41–90)

71 (46–94)

72 (41–85)

71 (46–91)

71 (44–90)

0.61a

PSA (median: ng/mL)

7.6 (0.3-5490)

7.6 (0.3–475)

7.6 (0.58–196)

7.2 (0.57–5490)

7.7 (1.0–864)

0.52a

No. of cores (median)

10 (6–12)

10 (6–12)

10 (6–12)

10 (6–12)

10 (6–12)

0.08a

GS 6 (%)

14.6 (n = 110)

17.2 (n = 34)

13.3 (n = 30)

11.9 (n = 22)

16.2 (n = 24)

0.51b

GS 3 + 4 (%)

11.1 (n = 84)

9.1 (n = 18)

12.0 (n = 27)

11.4 (n = 27)

8.1 (n = 12)

0.13b

GS 4 + 3 (%)

8.1 (n = 61)

5.6 (n = 11)

8.9 (n = 20)

7.0 (n = 13)

11.5 (n = 17)

0.23b

GS 8–10 %

6.6 (n = 50)

8.6 (n = 17)

6.2 (n = 14)

5.9 (n = 11)

5.4 (n = 8)

0.64b

  1. PSA Prostate specific antigen, GS Gleason score
  2. aKruskal-wallis test. bchi-square test